Arthur F Ryan
Director at Regeneron Pharmaceuticals, Inc. (REGN)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $435K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 7SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 200 | $650.15 | $130K | +11.7% |
| May 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 5 | $701.76 | $4K | +3.5% |
| May 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 15 | $702.46 | $11K | +3.4% |
| May 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 24 | $703.46 | $17K | +3.3% |
| May 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 15 | $704.28 | $11K | +3.2% |
| May 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 14 | $705.56 | $10K | +3.0% |
| May 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 7 | $706.74 | $5K | +2.8% |
| May 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 4 | $707.40 | $3K | +2.7% |
| May 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 6 | $709.45 | $4K | +2.4% |
| May 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 2 | $710.87 | $1K | +2.2% |
| May 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 5 | $711.49 | $4K | +2.1% |
| May 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 1 | $712.09 | $712 | +2.0% |
| May 4SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 2 | $714.13 | $1K | +1.7% |
| Apr 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 1 | $771.32 | $771 | -5.8% |
| Apr 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 3 | $772.76 | $2K | -6.0% |
| Apr 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 8 | $773.59 | $6K | -6.1% |
| Apr 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 8 | $774.58 | $6K | -6.2% |
| Apr 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 14 | $775.58 | $11K | -6.3% |
| Apr 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 13 | $776.62 | $10K | -6.5% |
| Apr 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 9 | $777.42 | $7K | -6.6% |
| Apr 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 4 | $778.24 | $3K | -6.7% |
| Apr 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 40 | $779.71 | $31K | -6.8% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 7 | $777.46 | $5K | -6.6% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 2 | $778.30 | $2K | -6.7% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 5 | $779.69 | $4K | -6.8% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 3 | $780.69 | $2K | -6.9% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 2 | $781.21 | $2K | -7.0% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 2 | $782.62 | $2K | -7.2% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 10 | $783.62 | $8K | -7.3% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 9 | $784.48 | $7K | -7.4% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 11 | $785.48 | $9K | -7.5% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 7 | $786.61 | $6K | -7.6% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 2 | $787.34 | $2K | -7.7% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 20 | $788.96 | $16K | -7.9% |
| Mar 3SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 20 | $789.28 | $16K | -8.0% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 1 | $775.63 | $776 | -6.3% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 10 | $776.59 | $8K | -6.5% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 57 | $777.56 | $44K | -6.6% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 12 | $778.53 | $9K | -6.7% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 5 | $779.41 | $4K | -6.8% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 1 | $780.09 | $780 | -6.9% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 5 | $781.48 | $4K | -7.0% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 1 | $782.53 | $783 | -7.2% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 3 | $783.34 | $2K | -7.3% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 1 | $784.59 | $785 | -7.4% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 1 | $785.71 | $786 | -7.5% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 2 | $786.29 | $2K | -7.6% |
| Feb 11SEC | REGNRegeneron Pharmaceuticals, Inc. | Sell Plan | 1 | $787.82 | $788 | -7.8% |
- Sell
Director Arthur F Ryan sold $130K of REGN at $650.15 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Arthur F Ryan sold $4K of REGN at $701.76 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Arthur F Ryan sold $11K of REGN at $702.46 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Arthur F Ryan sold $17K of REGN at $703.46 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Arthur F Ryan sold $11K of REGN at $704.28 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Arthur F Ryan sold $10K of REGN at $705.56 — pre-scheduled 10b5-1 plan sale.